{"title":"Recent Advances in the Use of Echocardiography in Cardio-Oncology","authors":"Malak El-Rayes, Maala Sooriyakanthan, Husam Abdel-Qadir, Paaladinesh Thavendiranathan","doi":"10.1007/s11936-023-01019-x","DOIUrl":"https://doi.org/10.1007/s11936-023-01019-x","url":null,"abstract":"","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"285 3-4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135217775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-05DOI: 10.1007/s11936-023-01017-z
Mustafa Husaini, Antonio Pelliccia, Vic Froelicher
{"title":"Historical and Current Differences Between Europe and the USA in Sports Cardiology","authors":"Mustafa Husaini, Antonio Pelliccia, Vic Froelicher","doi":"10.1007/s11936-023-01017-z","DOIUrl":"https://doi.org/10.1007/s11936-023-01017-z","url":null,"abstract":"","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"300 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134947610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.1007/s11936-023-01007-1
Saverio Tremamunno, Gaetano Antonio Lanza
Abstract Purpose of review To review data available in medical literature on the prognostic implications of the detection of an “early repolarization” (ER) pattern at standard electrocardiogram (ECG) in athletes, with particular reference to a possible increased risk of sudden death. Recent findings In 2010, a case–control study of patients with vs. without idiopathic ventricular fibrillation in athletes found a higher prevalence of infero-lateral slurring J wave in cases than controls (28.6% vs. 7.6%; p = 0.006). Subsequently, a few studies assessed the prognostic value of the ER pattern (J point/ST-segment elevation with a typical ascending morphology and/or J wave with a notched morphology or with slurred QRS) in populations of athletes. Overall, a number of 3882 athletes were included in 5 studies, 1330 of whom (34.3%) had some evidence of ER pattern. No case of sudden death, as well as no increased risk of cardiovascular events, was reported in these studies. Summary Our revision of population studies involving athletes in medical literature failed to find any apparent increase of the arrhythmic risk associated with ER/J wave, which, therefore, should be continued to be considered as benign findings on standard ECG.
摘要:回顾医学文献中关于运动员标准心电图(ECG)“早期复极”(ER)模式检测的预后意义，特别是可能增加猝死风险的文献。2010年，一项针对运动员特发性室性颤动患者与非特发性室性颤动患者的病例对照研究发现，患者的下外侧混浊J波患病率高于对照组(28.6% vs. 7.6%;P = 0.006)。随后，一些研究评估了ER模式(具有典型上升形态的J点/ st段抬高和/或具有缺口形态或模糊QRS的J波)在运动员群体中的预后价值。总的来说，5项研究共纳入3882名运动员，其中1330人(34.3%)有一定的ER模式证据。在这些研究中没有猝死病例，也没有心血管事件风险增加的报告。我们对医学文献中涉及运动员的人群研究进行了修订，并没有发现与ER/J波相关的心律失常风险明显增加，因此，应继续将其视为标准心电图的良性发现。
{"title":"Is Early Repolarization Syndrome a Risk for Sudden Cardiac Death in Young Athletes?","authors":"Saverio Tremamunno, Gaetano Antonio Lanza","doi":"10.1007/s11936-023-01007-1","DOIUrl":"https://doi.org/10.1007/s11936-023-01007-1","url":null,"abstract":"Abstract Purpose of review To review data available in medical literature on the prognostic implications of the detection of an “early repolarization” (ER) pattern at standard electrocardiogram (ECG) in athletes, with particular reference to a possible increased risk of sudden death. Recent findings In 2010, a case–control study of patients with vs. without idiopathic ventricular fibrillation in athletes found a higher prevalence of infero-lateral slurring J wave in cases than controls (28.6% vs. 7.6%; p = 0.006). Subsequently, a few studies assessed the prognostic value of the ER pattern (J point/ST-segment elevation with a typical ascending morphology and/or J wave with a notched morphology or with slurred QRS) in populations of athletes. Overall, a number of 3882 athletes were included in 5 studies, 1330 of whom (34.3%) had some evidence of ER pattern. No case of sudden death, as well as no increased risk of cardiovascular events, was reported in these studies. Summary Our revision of population studies involving athletes in medical literature failed to find any apparent increase of the arrhythmic risk associated with ER/J wave, which, therefore, should be continued to be considered as benign findings on standard ECG.","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134976528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-28DOI: 10.1007/s11936-023-01013-3
Óscar Cano, Pablo Jover, Pugazhendhi Vijayaraman
{"title":"Correction to: An Evidence‑Based Update on Physiological Pacing","authors":"Óscar Cano, Pablo Jover, Pugazhendhi Vijayaraman","doi":"10.1007/s11936-023-01013-3","DOIUrl":"https://doi.org/10.1007/s11936-023-01013-3","url":null,"abstract":"","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"184 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135386959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-28DOI: 10.1007/s11936-023-01014-2
Douglas J. Leedy, Marta Alhama-Belotto, William R. Gwin, Ruchi Kapoor, Elina Minami, Eric J. Chow, Richard K. Cheng
{"title":"Guidelines in Cardio-Oncology: The Balance Between Evidence and Expert Opinion","authors":"Douglas J. Leedy, Marta Alhama-Belotto, William R. Gwin, Ruchi Kapoor, Elina Minami, Eric J. Chow, Richard K. Cheng","doi":"10.1007/s11936-023-01014-2","DOIUrl":"https://doi.org/10.1007/s11936-023-01014-2","url":null,"abstract":"","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135386955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-15DOI: 10.1007/s11936-023-01011-5
Michael Griffin, Peter Calvert, Dhiraj Gupta
Abstract Purpose of Review Catheter ablation (CA) is a well-established treatment for paroxysmal atrial fibrillation (AF), but outcomes in persistent AF can be suboptimal. This review summarises recent evidence relating to the ideal patient population and target substrate for CA, and the techniques available. Recent Findings Risk scores can identify individuals with persistent AF who are more likely to benefit from CA. Pulmonary vein isolation (PVI) remains the most important ablation technique but non-pulmonary vein triggers explain the high recurrence rates in persistent AF. Novel electroanatomic mapping technologies, hybrid approaches, ethanol vein of Marshall ablation and thoracoscopic epicardial ablation are promising recent developments. Pulsed field ablation (PFA) is a new ablation modality with an excellent safety profile in trials to date; its role in persistent AF remains an area of study. Summary Improving outcomes of CA in persistent AF remains a significant research focus, with several encouraging directions for future study.
{"title":"Persistent Atrial Fibrillation Ablation: Ongoing Challenges Defining the Target Population and Substrate","authors":"Michael Griffin, Peter Calvert, Dhiraj Gupta","doi":"10.1007/s11936-023-01011-5","DOIUrl":"https://doi.org/10.1007/s11936-023-01011-5","url":null,"abstract":"Abstract Purpose of Review Catheter ablation (CA) is a well-established treatment for paroxysmal atrial fibrillation (AF), but outcomes in persistent AF can be suboptimal. This review summarises recent evidence relating to the ideal patient population and target substrate for CA, and the techniques available. Recent Findings Risk scores can identify individuals with persistent AF who are more likely to benefit from CA. Pulmonary vein isolation (PVI) remains the most important ablation technique but non-pulmonary vein triggers explain the high recurrence rates in persistent AF. Novel electroanatomic mapping technologies, hybrid approaches, ethanol vein of Marshall ablation and thoracoscopic epicardial ablation are promising recent developments. Pulsed field ablation (PFA) is a new ablation modality with an excellent safety profile in trials to date; its role in persistent AF remains an area of study. Summary Improving outcomes of CA in persistent AF remains a significant research focus, with several encouraging directions for future study.","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135437331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-15DOI: 10.1007/s11936-023-01006-2
Imran R. Masood, Jonathan B. Edelson
Abstract Purpose of review There are numerous health benefits to exercise, including improved cardiovascular, metabolic, and mental health. Despite these many benefits, children with cardiomyopathy have been traditionally restricted from engaging in exercise or participating in organized sports. The purpose of this review is to summarize the current literature regarding the utility of cardiopulmonary exercise testing, discuss the safety and benefits of exercise and sports participation in children with cardiomyopathy, and to identify research gaps in the field. Recent findings We highlight relevant literature discussing exercise and sports participation in children with hypertrophic cardiomyopathy, dilated cardiomyopathy, anthracycline-induced cardiomyopathy, and those with ventricular assist device support. We discuss recent literature describing methods for risk stratification. Summary The current literature globally favors promoting exercise and sports participation after appropriate risk stratification. Additionally, we offer guidance for how to safely promote exercise in children with cardiomyopathy.
{"title":"Exercise and Sports Participation in Children with Cardiomyopathy: A Review","authors":"Imran R. Masood, Jonathan B. Edelson","doi":"10.1007/s11936-023-01006-2","DOIUrl":"https://doi.org/10.1007/s11936-023-01006-2","url":null,"abstract":"Abstract Purpose of review There are numerous health benefits to exercise, including improved cardiovascular, metabolic, and mental health. Despite these many benefits, children with cardiomyopathy have been traditionally restricted from engaging in exercise or participating in organized sports. The purpose of this review is to summarize the current literature regarding the utility of cardiopulmonary exercise testing, discuss the safety and benefits of exercise and sports participation in children with cardiomyopathy, and to identify research gaps in the field. Recent findings We highlight relevant literature discussing exercise and sports participation in children with hypertrophic cardiomyopathy, dilated cardiomyopathy, anthracycline-induced cardiomyopathy, and those with ventricular assist device support. We discuss recent literature describing methods for risk stratification. Summary The current literature globally favors promoting exercise and sports participation after appropriate risk stratification. Additionally, we offer guidance for how to safely promote exercise in children with cardiomyopathy.","PeriodicalId":35912,"journal":{"name":"Current Treatment Options in Cardiovascular Medicine","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135437147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：